Key Takeaways
Long-term HRT use is linked to lower cardiovascular risk overall
Dr. Green noted that women who are appropriate candidates for HRT tend to have a longer, healthier life expectancy than those who never use it, largely due to estrogen's protective effect on blood vessels and heart tissue.
Starting HRT for the first time after 60 carries a different risk profile than continuing it
Dr. Cathleen Brown explained that beginning hormone therapy for the first time after age 60 raises cardiovascular risk in the first couple of years, but that risk doesn't apply to women who are already established on treatment before that age.
Breast cancer risk comes from the progesterone-estrogen combination, not estrogen alone
Dr. Cathleen Brown was clear that estrogen treatment itself does not increase breast cancer risk and may even lower it. The modest increase in risk shows up specifically when progesterone is combined with estrogen.
Hormone or blood testing isn't needed to guide HRT
Both doctors emphasized that major medical organizations, including the Menopause Society and ACOG, don't recommend baseline hormone labs since levels fluctuate too much to be useful. Treatment decisions are based on symptoms instead.
Hormone pellets carry more risk than traditional HRT
Dr. Green explained that pellets are typically testosterone-based, require an invasive insertion procedure, and can't be adjusted or removed easily if a patient has side effects — unlike creams, patches, or pills, which can be stopped or changed at any time.
